In the News
- UPDATED FEBRUARY 2026
Explore the science, conversations, and innovations shaping the next chapter of human optimization and wellness. From metabolic health and longevity to cognitive performance, emerging technologies, and thoughtful biohacking strategies, this curated collection brings together credible insights on what’s ahead in the science of feeling and functioning Way Better.
Metabolic Health & Emerging Therapies
Source: JAMA Network | Date: September 8, 2025
A JAMA Network Open study found GLP-1 therapies associated with reduced cardiovascular risk and consistent kidney benefits. Findings suggest outcomes may vary by body composition, supporting more personalized approaches to metabolic treatment.
Source: PMC (National Institutes of Health) | Date: October 9, 2025
A review examines how GLP-1 therapies support cardiovascular function and metabolic balance. Findings highlight their role in improving circulation, nutrient delivery, and overall cardiometabolic health across multiple biological systems.
PMC (National Institutes of Health) | Date: July 17, 2025
A review highlights how GLP-1 therapies support weight loss and cardiometabolic health while expanding into new conditions. Researchers also examine safety, long-term outcomes, and access challenges shaping their broader clinical use.
Source: NBC News | Date: December 1, 2025
A news segment examines the World Health Organization’s recommendation supporting GLP-1 medications for obesity treatment, highlighting growing public health recognition of obesity as a chronic disease requiring medical and lifestyle approaches.
Source: The Bossticks Podcast | Date: November 4, 2025
In this podcast episode, Dr. Terry Dubrow discusses GLP-1 medications, modern cosmetic treatments, and longevity strategies, explaining how medical therapies and lifestyle choices intersect in today’s evolving wellness landscape and preventive health approaches.
Source: Harvard School of Public Health | Date: February 25, 2026
A Harvard study found GLP-1 medications paired with healthy lifestyle habits significantly lowered cardiovascular risk in people with type 2 diabetes, highlighting how medical therapies and lifestyle changes work together to improve outcomes.
Source: HELLO! Magazine | Date: February 2026
After her 2023 pregnancy, Serena Williams lost more than thirty pounds using physician-guided GLP-1 therapy. Despite elite training and disciplined nutrition, she struggled losing weight without additional metabolic support for her health and well-being.
Source: People Magazine | Date: December 21, 2025
Oprah Winfrey openly shares how GLP-1 therapy changed her relationship with food after years of dieting and public scrutiny. She now views obesity as biological and describes reduced “food noise” and improved appetite regulation and metabolic signaling.
Source: Yale School of Medicine | Date: October 16, 2024
A Yale School of Medicine study found expanding access to modern obesity medications could prevent thousands of deaths annually by improving treatment for metabolic disease and reducing obesity-related health risks at the population level across diverse patient populations.
Source: Nature | Date: September 18, 2024
A Nature review examines how GLP-1 therapies regulate glucose, lipid metabolism, and cellular signaling across multiple systems. Findings highlight expanding applications in metabolic, cardiovascular, neurological, and inflammatory disease treatment.
Source: Washington University | Date: January 20, 2025
A large study of over two million patients found GLP-1 therapies linked to broad health benefits, including reduced neurological and cardiometabolic risks, while emphasizing the role of structured medical oversight and ongoing clinical monitoring.
Source: Today | Date: March 4, 2026
Kelly Clarkson shared that her weight loss followed health concerns including prediabetes and thyroid issues. With medical guidance, she focused on improving metabolic health rather than appearance, emphasizing long-term wellness and sustainable, physician-guided health improvements.
Source: Diabetes | Date: 2017
A peer-reviewed study examines dual incretin therapies combining GLP-1 and GIP signaling to improve metabolic outcomes. Findings suggest targeting multiple pathways may enhance weight loss, insulin response, and overall metabolic control.
Source: Cell Reports Medicine | Date: March 17, 2026
Emerging data suggests GLP-1 medications reduce fat more than muscle and maintain strength, challenging the narrative that these therapies inherently cause harmful muscle loss during rapid weight reduction, particularly in real-world clinical settings.
Hormones, Brain & Whole-Body Regulation
Source: The Joe Rogan Experience Podcast | Date: February 27, 2026
This podcast discussion explores public health perspectives on peptides and emerging therapies, including regulatory oversight, safety considerations, and the broader role scientific research plays in shaping future medical treatments.
Source: News Medical Life Sciences | Date: February 17, 2025
Researchers are exploring peptide-based medicines because they can interact precisely with cellular receptors and biological pathways, making them promising treatments for complex conditions including metabolic disorders, cancer, and neurological disease.
Source: Redox Medical Group
This podcast explores cellular medicine, including peptide therapies and biology. Discussion focuses on how cellular signaling, inflammation, and energy production influence metabolic health and chronic disease at the foundational level.
Source: The Jamie Kern Lima Show | Date: January 19, 2026
In this podcast, menopause specialist Dr. Mary Claire Haver explains how hormonal changes influence weight gain and metabolism, and discusses GLP-1 therapies, lifestyle habits, and strength-focused strategies to support long-term health and overall metabolic resilience.
Source: Seckin MD | Date: December 3, 2025
Researchers are exploring how GLP-1 therapies may influence inflammation, hormonal signaling, and pain pathways in endometriosis. While not a treatment, early findings suggest potential biological connections worth further clinical study and continued research exploration.
Source: National Library of Medicine | Date: November 24, 2022
A peer-reviewed review examines how GLP-1 therapies influence blood sugar, inflammation, and cardiovascular health. Findings highlight their expanding role in treating metabolic disease and supporting improved long-term outcomes.
Source: National Library of Medicine | Date: April 2016
A randomized clinical trial found enclomiphene citrate increased testosterone while preserving sperm counts in men with hypogonadism. Unlike topical testosterone, it supports natural hormone production rather than replacing endogenous testosterone.
Source: Redox Medical Group
This podcast explores cellular medicine, including peptide therapies and biology. Discussion focuses on how cellular signaling, inflammation, and energy production influence metabolic health and chronic disease at the foundational level.
Source: Healio | Date: February 12, 2025
Emerging research suggests GLP-1 therapies may influence brain pathways linked to addiction, depression, and cognition. Scientists are studying how these effects on reward signaling and inflammation could support broader neurological health applications.
Source: MDPI | Date: June 1, 2025
A scientific review examines how GLP-1 therapies influence brain signaling and reward pathways. Findings suggest potential roles in reducing addictive behaviors and supporting both metabolic and neuropsychiatric health in future clinical applications.
Source: Newsweek | Date: April 7, 2026
Research following nearly 100,000 people found semaglutide use linked to fewer mental health hospitalizations, lower rates of depression and anxiety, and reduced substance-use risk. Metabolic health, brain chemistry, and emotional well-being may be more connected than once thought.
The Next Chapter
is Waiting for You
For decades, research has shown what’s possible when health is approached proactively rather than reactively. Now that science is translating into real-world solutions. This isn’t just about a single treatment. It’s about optimizing how you look, feel, think, and age with tools designed for the future of wellness.
